Who
Kevin E. Lofton
Director
Company insider
Files Form 4 as: Director, Medtronic plc; Director, MiniMed Group; Director, Gilead Sciences; Director, Rite Aid.
In numbers
- Trades disclosed
- 136
- Buys
- 0
- Sells
- 1
- Bought
- $0
- Sold
- $287K
- Companies
- 4
- Companies where not an officer
- 4
- First trade
- 29 Jul 2009
- Last trade
- 15 Oct 2026
- Last filed
- 21 Oct 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 15 Oct 2026filed 21 Oct 2026 | MDT Medtronic plcMedical Devices | SEC FORM 4 Code J | —182 | filing |
| 15 Oct 2026filed 19 Oct 2026 | MMED MiniMed GroupMedical Devices | SEC FORM 4 Code A | —836 | filing |
| 9 Oct 2026filed 13 Oct 2026 | MMED MiniMed GroupMedical Devices | SEC FORM 4 Code A | —11,795 at $0.00 | filing |
| 28 Apr 2026filed 29 Apr 2026 | MDT Medtronic plcMedical Devices | SEC FORM 4 Code F | $17K207 at $81.90 | filing |
| 28 Apr 2026filed 29 Apr 2026 | MDT Medtronic plcMedical Devices | SEC FORM 4 Code F | $17K207 at $81.90 | filing |
| 27 Apr 2026filed 29 Apr 2026 | MDT Medtronic plcMedical Devices | SEC FORM 4 Code A | —2,111 at $0.00 | filing |
| 27 Apr 2026filed 29 Apr 2026 | MDT Medtronic plcMedical Devices | SEC FORM 4 Code A | —2,111 at $0.00 | filing |
| 9 Mar 2026filed 11 Mar 2026 | MMED MiniMed GroupMedical Devices | SEC FORM 4 Code A | —27,778 at $0.00 | filing |
| 9 Mar 2026filed 11 Mar 2026 | MMED MiniMed GroupMedical Devices | SEC FORM 4 Code A | —27,778 at $0.00 | filing |
| 29 Apr 2025filed 30 Apr 2025 | MDT Medtronic plcMedical Devices | SEC FORM 4 Code F | $18K216 at $84.60 | filing |
| 28 Apr 2025filed 30 Apr 2025 | MDT Medtronic plcMedical Devices | SEC FORM 4 Code A | $175K2,083 at $84.04 | filing |
| 1 May 2024filed 3 May 2024 | MDT Medtronic plcMedical Devices | SEC FORM 4 Code F | $16K192 at $80.89 | filing |
| 29 Apr 2024filed 1 May 2024 | MDT Medtronic plcMedical Devices | SEC FORM 4 Code A | $175K2,165 at $80.86 | filing |
| 28 Mar 2024filed 29 Mar 2024 | GILD Gilead Sciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —33.89 at $0.00 | filing |
| 28 Dec 2023filed 29 Dec 2023 | GILD Gilead Sciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —29.53 at $0.00 | filing |
| 28 Sep 2023filed 29 Sep 2023 | GILD Gilead Sciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —31.46 at $0.00 | filing |
| 29 Jun 2023filed 30 Jun 2023 | GILD Gilead Sciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —30.91 at $0.00 | filing |
| 3 May 2023filed 4 May 2023 | GILD Gilead Sciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | $808K10,173 at $79.45 | filing |
| 3 May 2023filed 4 May 2023 | GILD Gilead SciencesBiotechnology | SEC FORM 4 Code A | —1,887 at $0.00 | filing |
| 2 May 2023filed 3 May 2023 | MDT Medtronic plcMedical Devices | SEC FORM 4 Code F | $15K169 at $90.23 | filing |
News
Gilead Sciences (GILD) vs. AMGN and VRTX: Can Oncology Growth and HIV Strength Drive a New Growth Era Beyond Acquisitions?GILD · insidermonkey.com · 22 Oct 2026Gilead Sciences Is on an FDA Approval Hot Streak. Should You Buy the Stock Like There's No Tomorrow?GILD · fool.com · 18 Oct 2026Gilead Sciences Clears Its February High at $153.54GILD · 247wallst.com · 15 Oct 2026
0 headlines in the last 90 days name Kevin E. Lofton; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.